Personal information

No personal information available

Activities

Employment (1)

Università Campus Bio-Medico di Roma: Roma, Lazio, IT

2014-04-01 to present | PostDoc Position
Employment
Source: Self-asserted source
Michele Iuliani

Education and qualifications (4)

Università Campus Bio-Medico di Roma: Roma, Lazio, IT

2011-01-01 to 2014-12-31 | PhD in Bone Pathophysiology
Education
Source: Self-asserted source
Michele Iuliani

Università degli Studi di Roma La Sapienza: Roma, Lazio, IT

2008-01-01 to 2010-07-22 | Master Degree in Genetic and Molecular Biology
Education
Source: Self-asserted source
Michele Iuliani

Università degli Studi di Roma La Sapienza: Roma, Lazio, IT

2003-10-01 to 2007-12-17 | Bechelor Degree in Biological Science
Education
Source: Self-asserted source
Michele Iuliani

Università degli Studi di Roma La Sapienza: Roma, Lazio, IT

2003-10-01 to 2007-12-17 | Bechelor Degree in Biological Science
Education
Source: Self-asserted source
Michele Iuliani

Works (20)

S-p-bromobenzyl-glutathione cyclopentyl diester (BBGC) as novel therapeutic strategy to enhance trabectedin anti-tumor effect in soft tissue sarcoma preclinical models

Oncogene
2024-09-27 | Journal article
Contributors: F. Pantano; S. Simonetti; M. Iuliani; M. J. Guillen; C. Cuevas; P. Aviles; S. Cavaliere; A. Napolitano; A. Cortellini; A. Mazzocca et al.
Source: check_circle
Crossref

Circulating receptor activator of nuclear factor kappa-B ligand (RANKL) levels predict response to immune checkpoint inhibitors in advanced non-small cell lung cancer (NSCLC)

Journal for ImmunoTherapy of Cancer
2024-06 | Journal article
Contributors: Michele Iuliani; Sonia Simonetti; Leonardo Cristofani; Silvia Cavaliere; Alessio Cortellini; Marco Russano; Bruno Vincenzi; Giuseppe Tonini; Daniele Santini; Francesco Pantano
Source: check_circle
Crossref

Extensive plasma proteomic profiling revealed receptor activator of nuclear factor kappa-Β ligand (RANKL) as emerging biomarker of nivolumab clinical benefit in patients with metastatic renal cell carcinoma

Journal for ImmunoTherapy of Cancer
2022-09 | Journal article
Contributors: Sonia Simonetti; Michele Iuliani; Marco Stellato; Silvia Cavaliere; Bruno Vincenzi; Giuseppe Tonini; Daniele Santini; Francesco Pantano
Source: check_circle
Crossref

Osteoblast Secretome Modulated by Abiraterone Treatment Affects Castration Resistant Prostate Cancer Cell Proliferation

Biomedicines
2022-09 | Journal article | Author
Contributors: Michele Iuliani; Sonia Simonetti; Giulia Ribelli; Silvia Cavaliere; Bruno Vincenzi; Giuseppe Tonini; Francesco Pantano; Daniele Santini
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Large−Scale Profiling of Extracellular Vesicles Identified miR−625−5p as a Novel Biomarker of Immunotherapy Response in Advanced Non−Small−Cell Lung Cancer Patients

Cancers
2022-05 | Journal article | Author
Contributors: Francesco Pantano; Francesca Zalfa; Michele Iuliani; Sonia Simonetti; Paolo Manca; Andrea Napolitano; Simone Tiberi; Marco Russano; Fabrizio Citarella; Simone Foderaro et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Biological Effects of Cyclin-Dependent Kinase Inhibitors Ribociclib, Palbociclib and Abemaciclib on Breast Cancer Bone Microenvironment

International Journal of Molecular Sciences
2022-02 | Journal article | Author
Contributors: Michele Iuliani; Sonia Simonetti; Giulia Ribelli; Andrea Napolitano; Umile Giuseppe Longo; Bruno Vincenzi; Paolo Orsaria; Vincenzo Denaro; Giuseppe Tonini; Daniele Santini et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Antitumor Effect of Cabozantinib in Bone Metastatic Models of Renal Cell Carcinoma

Biology
2021-08 | Journal article | Author
Contributors: Michele Iuliani; Sonia Simonetti; Francesco Pantano; Giulia Ribelli; Alberto Di Martino; Vincenzo Denaro; Bruno Vincenzi; Antonio Russo; Giuseppe Tonini; Daniele Santini
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Integrin alpha5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesions

Oncogene
2021-02-18 | Journal article
Contributors: Francesco Pantano; Martine Croset; Keltouma Driouch; Natalia Bednarz-Knoll; Michele Iuliani; Giulia Ribelli; Edith Bonnelye; Harriet Wikman; Sandra Geraci; Florian Bonin et al.
Source: check_circle
Crossref

Dynamic changes of Receptor activator of nuclear factor-κB expression in Circulating Tumor Cells during Denosumab predict treatment effectiveness in Metastatic Breast Cancer

Scientific Reports
2020-01-28 | Journal article
Contributors: Francesco Pantano; Elisabetta Rossi; Michele Iuliani; Antonella Facchinetti; Sonia Simonetti; Giulia Ribelli; Alice Zoccoli; Bruno Vincenzi; Giuseppe Tonini; Rita Zamarchi et al.
Source: check_circle
Crossref

Skeletal Metastases of Unknown Primary: Biological Landscape and Clinical Overview

Cancers
2019-08-29 | Journal article
Contributors: Antonella Argentiero; Antonio Giovanni Solimando; Oronzo Brunetti; Angela Calabrese; Francesco Pantano; Michele Iuliani; Daniele Santini; Nicola Silvestris; Angelo Vacca
Source: check_circle
Crossref

Emerging drugs for the treatment of bone metastasis.

2015-06 | Journal article
Contributors: Pantano F; Iuliani M; Zoccoli A; Fioramonti M; De Lisi D; Fioroni I; Ribelli G; Santoni M; Vincenzi B; Tonini G et al.
Source: Self-asserted source
Michele Iuliani via Europe PubMed Central

Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment.

2015-05 | Journal article
Contributors: Iuliani M; Pantano F; Buttigliero C; Fioramonti M; Bertaglia V; Vincenzi B; Zoccoli A; Ribelli G; Tucci M; Vignani F et al.
Source: Self-asserted source
Michele Iuliani via Europe PubMed Central

Deregulation of dicer and mir-155 expression in liposarcoma.

2015-04 | Journal article
Contributors: Vincenzi B; Iuliani M; Zoccoli A; Pantano F; Fioramonti M; De Lisi D; Frezza AM; Rabitti C; Perrone G; Onetti Muda A et al.
Source: Self-asserted source
Michele Iuliani via Europe PubMed Central

MicroRNAs and bone metastasis: a new challenge.

2014 | Journal article
Contributors: Croset M; Santini D; Iuliani M; Fioramonti M; Zoccoli A; Vincenzi B; Tonini G; Pantano F
Source: Self-asserted source
Michele Iuliani via Europe PubMed Central
grade
Preferred source (of 2)‎

Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting.

2013 | Journal article
Contributors: Santini D; Zoccoli A; Gregorj C; Di Cerbo M; Iuliani M; Pantano F; Zamarchi R; Sergi F; Flammia G; Buscarini M et al.
Source: Self-asserted source
Michele Iuliani via Europe PubMed Central

Dicer and Drosha expression and response to Bevacizumab-based therapy in advanced colorectal cancer patients.

2013-04 | Journal article
Contributors: Vincenzi B; Zoccoli A; Schiavon G; Iuliani M; Pantano F; Dell'aquila E; Ratta R; Muda AO; Perrone G; Brunelli C et al.
Source: Self-asserted source
Michele Iuliani via Europe PubMed Central

Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw.

2012 | Journal article
Contributors: Vincenzi B; Napolitano A; Zoccoli A; Iuliani M; Pantano F; Papapietro N; Denaro V; Santini D; Tonini G
Source: Self-asserted source
Michele Iuliani via Europe PubMed Central

Premetastatic niche: ready for new therapeutic interventions?

2012-04 | Journal article
Contributors: Zoccoli A; Iuliani M; Pantano F; Imperatori M; Intagliata S; Vincenzi B; Marchetti P; Papapietro N; Denaro V; Tonini G et al.
Source: Self-asserted source
Michele Iuliani via Europe PubMed Central

New targets, new drugs for metastatic bone pain: a new philosophy.

2011-09 | Journal article
Contributors: Pantano F; Zoccoli A; Iuliani M; Lanzetta G; Vincenzi B; Tonini G; Santini D
Source: Self-asserted source
Michele Iuliani via Europe PubMed Central

Skeletal Metastases of Unknown Primary: Biological Landscape and Clinical Overview

Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎